Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Zinaida Good, Jay Y. Spiegel, Bita Sahaf, Meena Malipatlolla, Zachary Ehlinger, Sreevidya Kurra, Moksha H. Desai, Warren D. Reynolds, Anita Wong Lin, Panayiotis Vandris, Fang Wu, Snehit Prabhu, Mark Hamilton, John Tamaresis, Paul Hanson, Shabnum Patel, Steven A. Feldman, Matthew J. Frank, John H. Baird, Lori Muffly, Gursharan K. Claire, Juliana Craig, Katherine A. Kong, Dhananjay Wagh, John A. Coller, Sean C. Bendall, Robert Tibshirani, Sylvia K. Plevritis, David B. Miklos, Crystal L. Mackall
Topics & Concepts
Chimeric antigen receptorMedicineNeurotoxicityImmunologyCD19PopulationCell therapyAntigenCancer researchCellT cellToxicityBiologyInternal medicineImmune systemEnvironmental healthGeneticsCAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design